New treatments for drug-resistant gonorrhea
Sialic acid analogs against multidrug-resistant gonorrhea
This study is looking for new ways to treat gonorrhea that doesn't respond to regular antibiotics, and it aims to involve patients in testing these promising new treatments that could help make the infection easier to fight.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of Massachusetts Med Sch Worcester NIH-funded |
| Lab location | 1 site (Worcester, United States) |
| Project ID | NIH-11052605 on NIH RePORTER |
What this research studies
This research focuses on developing new therapies to combat multidrug-resistant gonorrhea, a significant public health issue. The approach involves using sialic acid analogs to disrupt the bacteria's ability to evade the immune system, making it more susceptible to treatment. By understanding how the bacteria interact with the immune system, researchers aim to create effective treatments that can address the growing problem of antibiotic resistance. Patients may be involved in trials to test these new therapies and contribute to the fight against this infection.
Who could benefit from this research
Good fit: Ideal candidates for participation would include individuals diagnosed with gonorrhea, particularly those with antibiotic-resistant strains.
Not a fit: Patients who do not have gonorrhea or those with non-resistant strains may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to effective treatments for gonorrhea that are resistant to current antibiotics.
How similar studies have performed: Other research has shown promise in developing novel therapies for antibiotic-resistant infections, indicating potential for success in this area.
Where this research is happening
Worcester, United States
- Univ of Massachusetts Med Sch Worcester — Worcester, United States (Active)
Researchers
- Principal investigator: Ram, Sanjay — Univ of Massachusetts Med Sch Worcester
- Study coordinator: Ram, Sanjay
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.